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Background: Nail bed injuries account for the majority of paediatric hand trauma cases. Despite their frequency,
controversy remains regarding their treatment. The accepted teaching is to remove the fingernail, repair the
underlying nail bed with fine sutures and replace the nail under the nail fold. A recent study by Miranda et al.
(Plast Reconst Surg. 129(2):394e-396e, 2012) suggests that replacing the nail is associated with increased complications,
in particular post-operative infection. Nail bed INJury Assessment Pilot (NINJA-P) is an external pilot study for a large
pragmatic, multicentre, randomised, controlled study (NINJA) to assess whether the nail should be replaced or discarded
after nail bed repair in children under the age of 16.
Methods/design: NINJA-P is a randomised pilot study. The participants are patients below 16 years of age who require
surgical repair of the nail bed. Eligible patients will be randomised to receive one of two possible interventions. Group 1
will have the nail replaced after nail bed repair, and group 2 will have the nail discarded. The clinical outcome measures
include the presence of post-operative complications at 2 weeks and 30 days, the cosmetic appearance of the nail at
4 months and the level of pain experienced by the child at their first dressings change at 2 weeks. In order to inform the
design of the main NINJA trial, the following feasibility data will also be recorded: the number of potentially eligible
children and the proportion which agree to take part in the study, the proportion of children who received the allocated
treatment and reasons for any non-compliance and the proportion of participants with a valid response at each
follow-up point. Neither the patient, family members nor treating physicians will be blinded. A replaced nail can
take several weeks to fall off once a new nail has grown out. The cosmetic appearance of the nail at 4 months
will be assessed by a blinded assessor.
Discussion: The NINJA-P pilot study will inform the design and execution of the NINJA trial, which will assess
whether the nail should be replaced or discarded after nail bed repair in children under 16. It will provide
randomised comparative evidence for the treatment of this common injury.
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Nail bed injuries are common and account for the ma-
jority of paediatric hand trauma cases treated by hand
surgery units. The typical patient is a toddler who has
caught their finger in a closing door. A single tertiary re-
ferral hand surgery unit will on average treat two to
three patients with nail bed injuries per day. This trans-
lates to between 730 and 1095 patients per year. The
tariff for a nail bed repair (figure from Guy’s and St
Thomas’ NHS Trust) is £1086, so this activity can be ex-
pected to generate between £792,780 and £1,189,170 of
income per annum for a NHS Trust and a significant ex-
pense to the NHS.
Despite their frequency, controversy remains around
the appropriate treatment of nail bed injuries [1, 2].
Without proper treatment, injury to the nail complex
has the potential to cause considerable dysfunction
and/or deformity [3–7]. The long-accepted teaching
has been to remove the nail plate (i.e. the fingernail),
repair the underlying matrix (i.e. nail bed) laceration
with fine absorbable sutures and replace the nail plate
under the eponychium (i.e. proximal nail fold, Fig. 1)
[8–11]. The replaced nail has no capacity for re-
growth. Instead, as a new nail begins to grow, the re-
placed nail is gradually pushed out until it becomes
loose. The rationale for replacing the nail is that it both
protects the nail bed repair and acts as a ‘splint’ by
holding open the nail fold and preventing scarring be-
tween the nail fold and the nail bed (synechiae). How-
ever, there is no evidence that replacing the nail has
better results than not replacing it.
A recent study by Miranda et al. suggests that
replacing the nail plate is associated with increased
complications, in particular, the development of post-
operative infection [12]. This retrospective study exam-
ined the outcomes of nail bed repairs in 111 children.
Overall complications occurred more frequently in
the nail replacement group (17.6 %) versus the nail
discarded group (5 %) (p < 0.001). In particular, theFig. 1 Anatomy of the fingertipoccurrence of delayed wound healing (11.7 versus 3.3 %;
p = 0.004) and post-operative infection (7.8 versus
0 %; p < 0.0001) was significantly greater in the nail
replacement group. There were significantly more
outpatient visits and a longer overall follow-up period re-
quired in the nail replacement group compared to the
nail discarded group. The authors advocate simply dis-
carding the nail plate and dressing the repaired nail bed
with a simple non-adherent dressing.
The reason for this apparent increase in infective and
wound healing complications is thought to be that the
replaced nail plate acts as a foreign body to ‘trap’ bac-
teria and make infection more likely. If this is the case,
the simple act of discarding the nail plate could result
in a significant reduction in the overall morbidity as-
sociated with this procedure, as well as a reduced bur-
den on the NHS associated with repeated follow-up
visits, antibiotic courses and, in severe cases, hospital
readmission.
Our own background research, including a nationwide
survey of orthopaedic and plastic surgeons, has found
that the vast majority (96 %) replace the nail plate with-
out great justification. A recent Cochrane review con-
cluded that “there is a lack of evidence from RCTs to
inform all key treatment decisions for the management
of fingertip entrapment injuries in children” and that
“further RCTs are required in this area” [13]. The au-
thors recommended that outcome assessment should be
at a minimum of 3 months post-treatment, as this repre-
sents the minimum time for a new nail to re-grow.
The Nail bed INJury Assessment (NINJA) study there-
fore seeks to answer the question “should the nail plate
be replaced or discarded after nail bed repair in children,
as evaluated by overall complications and appearance of
the nail (co-primary outcome measures)?” A consensus
meeting was held at the Royal College of Surgeons in
February 2014 to discuss the protocol (which in-
cluded surgeons from across the country along with
methodologists). A number of key uncertainties exist
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recruitment feasibility, outcome measures and trial path-
way appropriateness. This pilot study will assess these
and inform the design of the anticipated subsequent mul-
ticentre randomised controlled trial (NINJA). A 4-month
follow-up time point will be used in the pilot study
whereas the main study will require longer term follow-
up as it is recognised that subtle improvements in the
cosmesis of the nail will occur with subsequent growth
cycles.
Methods/design
Objectives of the study
NINJA-P is an external pilot study for a large pragmatic,
multicentre, randomised, controlled study (NINJA Trial)
to assess whether the damaged nail should be replaced
or discarded after nail bed repair in children under 16.
The primary objective of NINJA-P is to inform the de-
sign of the anticipated subsequent main NINJA study
specifically in terms of feasibility of recruitment and data
collection. In order to achieve this, a range of feasibility
measures and clinical outcomes will be collected as
listed below.
The feasibility measures are as follows:
1. Number of potentially eligible children
2. Number of patient/parents and guardian’s
approached to take part in the study
3. Proportion of children for whom consent was sought
which took part in the study
4. Proportion of children who received the allocated
treatment and reasons for any non-compliance
5. Proportion of participants with a valid response at
each follow-up point (for 4-month time point both
overall and only by method of follow-up)
The patient-centred outcome measures are as follows:
1. The presence of post-operative complications at
2 weeks and 30 days
2. The cosmetic appearance of the nail at 4 months
3. The level of pain experienced by the child at their
first dressing change at 2 weeks
The secondary study objectives are to inform the de-
sign and conduct of the main NINJA trial as follows:
1. Identify any conflicts or areas of concern for the
research pathway compared with the existing
standard clinical pathway.
2. Assess suitability of outcome measures for children
in this setting.
3. Quantify event proportion and variability data to
help inform a sample size calculation for main study.Recruitment
Trial participants will be prospectively recruited for the
trial from the participating hospitals (Guy’s and St
Thomas’ Hospitals NHS Trust, London, UK; Mid Essex
Hospitals NHS Trust, Chelmsford, UK; Hull and East
Yorkshire Hospitals NHS Trust, Hull, UK; Oxford
University Hospitals NHS Trust, Oxford, UK). Screening
and eligibility assessment will take place when the pa-
tient is first seen by a member of the specialist surgical
team in the emergency department or paediatric ward of
the participating unit. In the majority of cases, this task
will be performed by a trainee surgeon (Foundation
Year, Core Trainee or Specialist Trainee grade).
The setting in which the patient is first seen will de-
pend on the local protocol at the participating hospital.
For example, in some hospitals, the specialty surgeon
will be asked to see patients in the emergency depart-
ment by a referring emergency practitioner. In other
hospitals, the specialty surgeon may ask the referring
practitioner to send the patient to a paediatric ward, or
other assessment area, for review. In either circum-
stance, it will only be a member of the specialist surgical
team who will perform screening and eligibility assess-
ment, not a member of the emergency department or
paediatric team. Ultimately, the patient will always be
asked to attend a paediatric ward prior to surgery.
The eligibility assessment will require examination of
the child’s fingertip with the dressings removed, com-
bined with review of the child’s radiographs, if indicated
(e.g. in crush injuries), to check for the presence of a
fracture. Parents of eligible patients will be asked by
the assessing surgeon if they would like their child to
take part in the trial and be provided with the age-
appropriate information sheets. It is anticipated that, in
most circumstances, consent will be sought by the same
person carrying out the eligibility assessment and in the
same setting. Depending on the resources of the partici-
pating unit, there will be several Good Clinical Practice
(GCP)-trained trainees and/or consultant surgeon(s)
capable of performing both the eligibility assessment and
consent process. In some units, the consent process may
be undertaken by a research nurse, after the patient has
been deemed eligible for the study by a specialty surgeon.
These roles will be recorded in the centre’s delegation log.
Informed consent
The parent(s) or legal guardian of patients enrolled in
the study will need to give informed, written consent
preoperatively. Consent will be obtained by individuals
who are trained in GCP and consent and who are listed
on the delegation log. Written and verbal versions of the
participant information and informed consent will be
presented to the participants parents/legal guardians de-
tailing no less than the exact nature of the study, what it
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straints of the protocol and any risks involved in taking
part.
It will be clearly stated that the child is free to with-
draw from the study at any time for any reason without
prejudice to future care and with no obligation to give
the reason for withdrawal. Consent for medical photog-
raphy will be included as part of the consent process.
The patients themselves will also be provided with an in-
formation sheet telling them about the study. Separate
patient information sheets will be available for the fol-
lowing age groups under 6, 6–10, 11+. If, having had
adequate time to make a decision, the parent or legal
guardian is happy to give their consent, this will be re-
corded by means of a signature on a standardised con-
sent form for the study.
Number of participants
The target sample of size of this study is 60 patients. A
study of this size would be sufficient to generate a binary
feasibility measure with a 95 % confidence interval width
of between 15 and 25 % depending upon the event pro-
portion based upon the Wald interval [14].
Eligibility criteria
Inclusion criteria
 Aged below 16 years of age
 Acute nail bed injury (occurring within 48 h of
presentation at trial centre) requiring surgical repair
 Injury-type includes sharp lacerations, stellate
lacerations, crush and avulsion injuries of the nail
bed, injuries involving the sterile and/or germinal
matrix, nail bed injuries with an associated pulp
laceration and/or with an associated ‘tuft’ fracture of
the distal phalanx
 Patients whose parent or legal guardian consent to
their inclusion in the trial and are willing to return
for follow-up
Exclusion criteria
 Patients aged 16 years or over will be excluded.
 Patients who present with an already infected nail
bed injury.
 Patients with underlying nail disease or deformity
prior to the injury.
 Patients with an associated distal phalanx fracture
requiring fixation with a Kirschner wire. This is
considered to be another potential source of
infection and therefore a confounding variable.
 Patients with complete amputation of the distal
fingertip including all or part of the nail bed, which
requires repair as a composite graft or replantation. Patients with loss of part or all of the nail bed
requiring a nail bed graft or flap reconstruction.
 Non-English speaking individuals.
Interventions
Eligible patients will be randomised to receive one of
two possible surgical interventions (Fig. 2). The surgery
will be performed by a surgeon adequately trained to be
able to undertake a nail bed repair in line with the re-
quirements of the study. This will usually be the surgical
trainee assigned to trauma that day or the trauma fellow.
Intervention 1: replaced nail (group 1)
Group 1 will have the nail plate replaced after nail bed
repair. The nail bed repair will be performed after ad-
equate washout and debridement, and the repair com-
pleted using 6/0 or 7/0 interrupted sutures. The nail
plate will be secured using a figure-of-eight Vicryl
Rapide suture, orientated in the longitudinal axis. If the
nail plate cannot be replaced in a patient randomised to
group 1, for example, if it is too badly damaged, a nail
substitute of the operating surgeon’s choice will be used.
Intervention 2: discarded nail (group 2)
Group 2 will have the nail plate discarded after the nail
bed repair. The washout and debridement and suturing
procedures will be the same as described for the first
group.
This will be a pragmatic study; hence, the following
decisions (whichever arm of the study the patient is in)
will be left to the discretion of the surgical team respon-
sible for the patient and recorded appropriately:
 The type of anaesthetic used (general or local, or
both). No stipulation will be made regarding the
type of anaesthetic to be used. In this age group, it is
normal for the majority of cases to be performed
under general anaesthetic as it is uncommon for a
young child to be cooperative enough to tolerate a
local anaesthetic procedure.
 Perioperative antibiotics given, if any.
 Type of tourniquet used.
 Type of wash used.
The fingertip will be dressed with the same non-
adherent dressing in both groups.
Participants in NINJA-P are additionally being rando-
mised to receive one of two follow-up methods for data
collection at 4 months (in a manner similar to a SWAT
[15]). Half of the patients will be seen in clinic at
4 months to assess the cosmetic appearance of their fin-
gernail. The other half will be followed up remotely
using a postal questionnaire, which will also involve ask-
ing parents to take photographs of their child’s repaired
GROUP 1                




GROUP 2               
Nail Discarded         
(n=30)
Followed-Up to 4 months
Primary outcome assessed at 
4 months (appearance)
Follow-up feasibility measures:
Proportion of 4 month parent and clinic 
assessment completed
Proportion of patients withdrawing
Proportion of patients with completed 
assessment at baseline, 2 weeks & 30 days
Consent & Baseline
Surgery (nail replaced)
Operative assessment      
Followed-Up to 4 months
Primary outcome assessed at 
4 months (appearance)
Surgery (nail discarded)
Operative assessment      
Fig. 2 Flow chart of the study
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the photographs to a secure address for assessment.
Randomisation
A web-based randomisation system will be provided by
the Oxford Clinical Trials Research Unit (OCTRU) with
allocation stratified by site and formed of random per-
muted blocks of varying size. Each participant will re-
ceive two allocations, one for treatment and one for
method of follow-up at 4 months (see below for further
details). Randomisation will, ideally, take place when the
patient is in the anaesthetic room, just prior to surgery.
A member of the local research team, who will not be
blinded to the treatment, will complete the randomisa-
tion process. This will require secure login to the web-
based randomisation system by a computer or handheld
device connected to the internet. The computer
programme will ask for confirmation that the inclusion
criteria have been met and that no exclusion criteria are
present. Eligible participants will be assigned a unique
trial number, and the programme will inform the re-
search team member of the surgical intervention the
participant should undergo and which follow-up method
they have been allocated to for the 4-month time point.
The designated intervention will be recorded in the case
report form (CRF) and, if the person randomising the
patient is not the operating surgeon, this information
will be relayed to the operating surgeon before the start
of the operation.
Feasibility data collection
The trial coordinator will collate information from
screening logs, change of status forms and from the
completion of the follow-up questionnaires throughoutthe trial. Screening log data will provide information re-
garding the number of potential patients who were
approached, the number who decline and any given rea-
sons for this. Change of status forms will inform the
study group of reasons patients withdrew, or were with-
drawn by their clinician, from their randomised treat-
ment and/or follow up. The trial database will provide
information about the completeness of study forms and
attendance at follow-up appointments. The coordinator
will also monitor and record feedback from patients/
parents and participating clinicians in relation to the
follow-up schedule and the content of the CRFs and
patient questionnaire.
Baseline assessments and operative assessments
Baseline assessment: day of operation, acute hospital
setting (emergency department, paediatric ward,
operating theatre)
Patient demographics will be recorded on the CRF when
the patient is seen by the assessing surgeon on admis-
sion in the emergency department or the paediatric
ward. Data recorded will include hospital number, date
of birth, sex, pre-existing health problems and regular
medications, the digit involved, the method of injury and
the presence or absence of a fracture (Fig. 3).
Operative assessment
At the time of surgery, the operating surgeon will clas-
sify the nail bed injury according to the system proposed
by Zook et al. [10] and record this on the CRF. Details
of the operation carried out, including whether or not
the nail was replaced, operative complications, if a nail
substitute was used, type of anaesthetic used, any antibi-
otics given, operative and tourniquet time and the grade
Fig. 3 The Wong-Baker FACES pain rating scale
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corded. Any procedures which might lead to exclusion
of the patient from the study (such as insertion of a
Kirschner wire) will also be recorded, and the principal
investigator for the site will be informed.
Follow-up assessments
Participating patients will be required to attend hospital
for assessment of patient-centred outcomes at the fol-
lowing time points:
2 weeks, clinic
The dressings from surgery will be removed in clinic by
either the surgeon or a nurse. It is not routine practice
to give analgesia to children prior to having their dress-
ings removed. However, as this is a pragmatic study, if
analgesia is required, this will be recorded on the CRF.
The level of pain reported by the patient according to
the Wong-Baker FACES pain rating scale [16] will be re-
corded on the CRF by a clinical research nurse or at-
tending surgeon (Fig. 3). This pain scale has been
validated for scoring acute pain in children presenting at
the emergency department [17] and is therefore consid-
ered an appropriate means of scoring the acute pain as-
sociated with removing a dressing from over a wound.
The member of the research team recording the pain
level will also assess the child’s fingertip for the absence
or presence or of any complications (including infection
as defined according to Centers for Disease Control
(CDC) definition of surgical site infection [18]) and rec-
ord these on the CRF. Information about any further
treatment sought since their operation will also be col-
lated. Complications will be treated as clinically indi-
cated. The fingertip will be re-dressed with a simple
non-adherent dressing, either by the surgeon or a nurse.
30 days, clinic
The fingertip will again be assessed by a clinical research
nurse or attending surgeon for the presence or absence
of any complications. Information about any furthertreatment sought in between follow-up assessment time
points will also be collated. These will be recorded on
the CRF. Complications will be treated as clinically
indicated.
4 months, clinic and photograph submission
Half of the patients will be seen in clinic at 4 months to
assess the cosmetic appearance of their fingernail. The
decision as to who will attend the clinic for the 4-month
visit and who will just send a photo will have been made
at time of randomisation. During the clinic review, a
standardised photograph will be taken of the fingernail.
This will be taken by a surgeon or clinical research nurse
when the child attends clinic using a digital camera. The
photograph will include both the affected fingernail and
contralateral normal fingernail for comparison. An ex-
ample of a standardised photograph, with the format re-
quired, will be available in the clinic for guidance.
The photograph will be assessed by a different clin-
ician, who is blinded to the intervention the patient
received. This clinician will evaluate the cosmetic ap-
pearance of the fingernail using a previously validated
physician-based outcome tool developed by Zook et al.
[10] (Fig. 4). Based on this scoring system, an excellent
outcome for the repaired fingernail is defined as one that
is identical in appearance to the same finger on the
contralateral hand. A very good result exhibits one vari-
ation from identical, such as incomplete adherence, nail
ridging, split nails or eponychial deformity. A good re-
sult exhibits two minor variations from identical. A poor
cosmetic result exhibits more than three variations or
one major variation from the same fingernail on the
contralateral hand. Whilst in clinic, the patient’s parent
will also be asked to rate the appearance of their child’s
fingernail using a visual analogue scale (VAS). Informa-
tion about any further treatment sought in between
follow-up assessment time points will also be collated.
Those patients who are randomised to attend clinic at
4 months and who fail to attend for follow-up will be
contacted by telephone and/or e-mail by a research


























































































































Fig. 4 The Zook classification of fingernail appearance. All split nails, nails with less than two-thirds adherence and very rough nails are considered
major deformities. Other deformities are considered minor. The sum of the minor and major variations for each fingertip are used to determine a
grade of excellent, very good, fair, or poor for each result
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photograph of their child’s repaired fingernail and the
contralateral fingernail on the other hand for compari-
son as per the instructions on the email/letter sent to
them. They will also be asked to e-mail their rating of
the appearance of their child’s fingernail using the VAS
which will be included in the e-mail.
The other half of the patients will be posted a short
questionnaire asking about any further treatment sought
since their 30-day assessment. A VAS will also be in-
cluded for the parent and the child to rate the appear-
ance of the fingernail. Parents will also be asked to take
a photograph of the nail and send it to a secure email.
These images will be collated centrally by the study team
in Oxford, anonymised and sent onto independent,
blinded assessors. These clinicians will be identified by
the study team prior to the start of recruitment. Parents
will be asked to send a digital photograph of their child’s
fingernail by email to a study email account using the
standardised format. An example of a standardised
photograph, with the format required, will be sent to the
parent for guidance.
Blinding
NINJA-P is an open study in that those delivering the
care will not be blinded to the intervention, nor the pa-
tient (and family members) who receives it. A replaced
nail can take several weeks to loosen and fall off once a
new nail has grown out. The only time that those in-
volved in post-intervention assessment of the nail will be
blinded is at the 4-month review. By this time, it is antic-
ipated that all of the replaced nails will have fallen off
and been replaced by a new nail. The assessment of the
photographs for cosmetic appearance at 4 months will
be carried out by a blinded assessor.
Outcomes and analysis
A single analysis of data will take place once the study
has ceased recruiting and the last participant has com-
pleted their final assessment. No interim analysis of datais planned nor is a statistical comparison of outcome by
treatment group. Descriptive analyses of outcome data
will be carried out using appropriate summary measures
(e.g. number of events and percentage for binary mea-
sures). Outcome data will be grouped according to the
allocated intervention irrespective of the actual treat-
ment received. Feasibility measures will be quantified
and where appropriate an associated 95 % confidence
interval calculated using the Wilson Score Interval
method for binary measures. All analyses will be carried
out using Stata 13.0 (StataCorp. 2013. Stata: Release 13.
Statistical Software. College Station, TX: StataCorp LP.).
No imputation of missing data will be carried out.
Withdrawal from the study will result in exclusion of
that participant’s data from analysis. If, during the course
of surgery, the surgeon has to perform a procedure(s),
which was part of the exclusion criteria, this will be re-
corded on the CRF. This is an extremely unusual event
as the vast majority of these procedures (e.g. fracture fix-
ation with a Kirschner wire, need for composite graft or
nail bed graft) are predictable pre-operatively. These pa-
tients will remain in the trial.
Ethical approval
Ethical approval for the trial was granted via Proportionate
Review by National Research Ethics Service Committee,
South East Cost-Surrey on the 21 January 2015. The
Research Ethics Committee (REC) Reference is 15/LO/
0067.
Discussion
Nail bed injuries are the most common paediatric hand
injury, yet there is a limited evidence base to guide treat-
ment. It is common practice to replace the nail after
repairing the nail bed, but this is not known to improve
the outcome and may even be associated with increased
post-operative complications including infection.
The results of the NINJA-P pilot study will inform the
design and execution of the main NINJA trial. It will
achieve this by resolving key uncertainties relating to the
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tients that present with nail bed injuries over a defined
period of time, the proportion of children who agree to
take part in the study, the proportion of children who
then go on to receive the allocated treatment, reasons
for any non-compliance and the proportion of partici-
pants with a valid response at each follow-up point. As
this is a research community with limited previous in-
volvement in clinical trials, NINJA-P will provide im-
portant practical evidence regarding the conduct of trials
in this area. Potential limitations may be that the sites
involved in this study may be more engaged than some
of those likely to be involved in the main NINJA trial.
The design of NINJA-P and the plan for the subsequent
NINJA trial reflect clinical practicalities in terms of care
of children requiring a nail bed repair (differences in ap-
proach between surgeons and sites) and also the limited
scope of blinding attempted.
Based on this information, the NINJA trial will then
fully assess whether the damaged nail should be replaced
or discarded after nail bed repair in children. This large,
pragmatic, multicentre, randomised, controlled study
will enable the current lack of evidence regarding the
treatment of this common injury to be addressed.
Trial status
Participant enrolment commenced in April 2015 and is
scheduled to be complete by the end of July 2015.
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